Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mukka ProteinsNSE:MUKKA +2.38%40 EV-to-EBIT is 11.05 as of Sep. 11, 2026, which is 6% below its 10-year median of 11.75. GuruFocus rates NSE:MUKKA with a GF Score™ of 40/100. The stock has 7 warning signs investors should review. Among 1,565 Consumer Packaged Goods companies, Mukka Proteins ranks better than 57.57% on this metric.
The historical rank and industry rank for Mukka Proteins's EV-to-EBIT or its related term are showing as below:
NSE:MUKKA'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.25 Med: 11.75 Max: 23.13
Current: 11.04
During the past 8 years, the highest EV-to-EBIT of Mukka Proteins was 23.13. The lowest was 4.25. And the median was 11.75.
NSE:MUKKA's EV-to-EBIT is ranked better than 57.57% of 1565
companies
in the Consumer Packaged Goods industry
Industry Median: 12.39
vs NSE:MUKKA: 11.04
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Mukka Proteins's Enterprise Value for the quarter that ended in Jun. 2026 was ₹7,146 Mil.
Mukka Proteins's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,592 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukka Proteins EV-to-EBIT Related Terms
Mukka Proteins EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Mukka Proteins's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Mukka Proteins's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mukka Proteins EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Mukka Proteins's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Mukka Proteins's EV-to-EBIT falls into.
Mukka Proteins's current Enterprise Value is ₹17,582 Mil.
Mukka Proteins's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,592 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukka Proteins (NSE:MUKKA) has a EV-to-EBIT of 11.05 as of Sep. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mukka Proteins and its competitors. This is near median its historical median of 11.75. Over the past decade, Mukka Proteins' EV-to-EBIT has ranged from 4.25 to 23.13. According to the industry distribution chart, Mukka Proteins ranks #664 out of 1565 companies in the Consumer Packaged Goods industry, placing it in the top 42.4%.
Is Mukka Proteins' EV-to-EBIT too high?
Mukka Proteins' current EV-to-EBIT of 11.05 is near median its 10-year median of 11.75. Over the past 10 years, this metric has ranged from a low of 4.25 to a high of 23.13. The Consumer Packaged Goods industry median EV-to-EBIT is 12.39. Mukka Proteins' value of 11.05 is 10.8% below this industry median. Based on the distribution chart, Mukka Proteins ranks #664 out of 1565 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Mukka Proteins has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Mukka Proteins' EV-to-EBIT compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Mukka Proteins ranks #664 out of 1565 companies for EV-to-EBIT. This puts Mukka Proteins in the upper half of its industry. The industry median EV-to-EBIT is 12.39. Mukka Proteins' value of 11.05 is 10.8% below this benchmark. Historically, Mukka Proteins' own EV-to-EBIT has ranged from 4.25 to 23.13 over the past decade. While the company's 10-year median is 11.75 vs. the industry median of 12.39, Mukka Proteins has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.39, based on 1,565 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mukka Proteins's current EV-to-EBIT of 11.05 is 10.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mukka Proteins and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mukka Proteins's current EV-to-EBIT is 11.05, which is near median its own 10-year median of 11.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukka Proteins stock overvalued right now?
Mukka Proteins (NSE:MUKKA) has a current EV-to-EBIT of 11.05. The current EV-to-EBIT is 11.05, which is near median its 10-year median of 11.75 and 10.8% below the Consumer Packaged Goods industry median of 12.39. Mukka Proteins' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Mukka Proteins (NSE:MUKKA), the current EV-to-EBIT is 11.05 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mukka Proteins Ltd is an animal protein company. The company manufactures and supplies fish meal, fish oil, and fish soluble paste, which is an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broilers and layers), and pet food. Fish oil of the company also finds its application in pharmaceutical products (additionally, Omega-3 pills and related products derived from fish oil are gaining importance as high-nutrient and healthy dietary supplements), soap manufacturing, leather tanneries & paint industries. The company sells its products domestically and also exports them to over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam.
40GF Score
Get the complete analysis for NSE:MUKKA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MUKKA has been successfully added to your 
